Therapeutic Potential of Pistacia Atlantica Gum in Aspirin-Induced Peptic Ulcers: A Dose-Dependent Approach to Mucosal Protection and Hepatorenal Safety.

IF 2.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Kourosh Sayehmiri, Somayeh Heidarizadi, Kamyar Sayehmiri, Monireh Azizi
{"title":"Therapeutic Potential of Pistacia Atlantica Gum in Aspirin-Induced Peptic Ulcers: A Dose-Dependent Approach to Mucosal Protection and Hepatorenal Safety.","authors":"Kourosh Sayehmiri, Somayeh Heidarizadi, Kamyar Sayehmiri, Monireh Azizi","doi":"10.2174/0115665240445451260611091700","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Aspirin-induced peptic ulcers present a major clinical challenge, driving the search for safer, natural gastroprotective agents. This study evaluated the therapeutic potential and safety of Pistacia atlantica gum (PAG) in a rat model of aspirin-induced gastric damage.</p><p><strong>Materials and methods: </strong>Forty-nine male Wistar rats were divided into seven groups (n=7): normal control, aspirin control, aspirin + vehicle, aspirin + PAG (3, 6, or 12 mg/kg), and aspirin + sucralfate (70 mg/kg, positive control). Ulcers were induced by oral aspirin (200 mg/kg for 3 days). Treatments were administered for two weeks. Assessments included ulcer scoring, serum biochemical markers (ALT, AST, ALP, GGT, BUN, creatinine), oxidative/antioxidant status (MDA, SOD), inflammatory cytokines (IL-6, TNF-α), and blinded histopathological evaluation.</p><p><strong>Results: </strong>PAG exhibited a dose-dependent reduction in ulcer severity, with the 12 mg/kg dose achieving efficacy comparable to sucralfate. Biochemically, PAG 12 mg/kg significantly ameliorated aspirin-induced hepatotoxicity (reduced ALT, AST, ALP, and GGT) and nephrotoxicity (reduced BUN and creatinine), surpassing sucralfate, which showed no renal benefit. PAG treatment also mitigated oxidative stress (increased SOD, decreased MDA) and suppressed pro-inflammatory cytokines (IL-6, TNF-α). Histopathological analysis confirmed significant mucosal preservation in PAG-treated groups.</p><p><strong>Discussion: </strong>The study highlights PAG's multifaceted therapeutic profile, aligning with its traditional use in Kurdish medicine. Its efficacy is likely associated with phytochemicals such as α-pinene and flavonoids, which are suggested to modulate oxidative stress, inflammation, and apoptosis pathways. Notably, PAG may offer a safer profile, as it lacks nephrotoxic effects and exhibits hepatorenal protective properties.</p><p><strong>Conclusion: </strong>PAG emerges as a potent natural remedy for aspirin-induced ulcers, combining mucosal protection with systemic safety.</p>","PeriodicalId":10873,"journal":{"name":"Current molecular medicine","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2026-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current molecular medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0115665240445451260611091700","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Aspirin-induced peptic ulcers present a major clinical challenge, driving the search for safer, natural gastroprotective agents. This study evaluated the therapeutic potential and safety of Pistacia atlantica gum (PAG) in a rat model of aspirin-induced gastric damage.

Materials and methods: Forty-nine male Wistar rats were divided into seven groups (n=7): normal control, aspirin control, aspirin + vehicle, aspirin + PAG (3, 6, or 12 mg/kg), and aspirin + sucralfate (70 mg/kg, positive control). Ulcers were induced by oral aspirin (200 mg/kg for 3 days). Treatments were administered for two weeks. Assessments included ulcer scoring, serum biochemical markers (ALT, AST, ALP, GGT, BUN, creatinine), oxidative/antioxidant status (MDA, SOD), inflammatory cytokines (IL-6, TNF-α), and blinded histopathological evaluation.

Results: PAG exhibited a dose-dependent reduction in ulcer severity, with the 12 mg/kg dose achieving efficacy comparable to sucralfate. Biochemically, PAG 12 mg/kg significantly ameliorated aspirin-induced hepatotoxicity (reduced ALT, AST, ALP, and GGT) and nephrotoxicity (reduced BUN and creatinine), surpassing sucralfate, which showed no renal benefit. PAG treatment also mitigated oxidative stress (increased SOD, decreased MDA) and suppressed pro-inflammatory cytokines (IL-6, TNF-α). Histopathological analysis confirmed significant mucosal preservation in PAG-treated groups.

Discussion: The study highlights PAG's multifaceted therapeutic profile, aligning with its traditional use in Kurdish medicine. Its efficacy is likely associated with phytochemicals such as α-pinene and flavonoids, which are suggested to modulate oxidative stress, inflammation, and apoptosis pathways. Notably, PAG may offer a safer profile, as it lacks nephrotoxic effects and exhibits hepatorenal protective properties.

Conclusion: PAG emerges as a potent natural remedy for aspirin-induced ulcers, combining mucosal protection with systemic safety.

阿斯匹林诱导的消化性溃疡的治疗潜力:一种剂量依赖性的粘膜保护和肝肾安全方法。
导论:阿司匹林引起的消化性溃疡目前是一个重大的临床挑战,推动寻找更安全,天然的胃保护剂。本研究评估了阿斯匹林诱导的大鼠胃损伤模型中阿斯匹林胶(PAG)的治疗潜力和安全性。材料与方法:雄性Wistar大鼠49只,随机分为7组(n=7):正常对照组、阿司匹林对照组、阿司匹林+对照、阿司匹林+ PAG(3、6、12 mg/kg)、阿司匹林+硫糖铝(70 mg/kg,阳性对照)。口服阿司匹林(200 mg/kg,连续3 d)诱导溃疡。治疗持续两周。评估包括溃疡评分、血清生化指标(ALT、AST、ALP、GGT、BUN、肌酐)、氧化/抗氧化状态(MDA、SOD)、炎症因子(IL-6、TNF-α)和盲法组织病理学评价。结果:PAG在溃疡严重程度上表现出剂量依赖性降低,12mg /kg剂量达到与硫糖酸钠相当的疗效。生物化学方面,PAG 12 mg/kg显著改善了阿司匹林引起的肝毒性(降低ALT、AST、ALP和GGT)和肾毒性(降低BUN和肌酐),优于硫糖钠,后者对肾脏没有益处。PAG处理还可以减轻氧化应激(SOD升高,MDA降低)和抑制促炎细胞因子(IL-6, TNF-α)。组织病理学分析证实,pag处理组粘膜保存明显。讨论:该研究突出了PAG的多方面治疗概况,与其在库尔德医学中的传统用途一致。其功效可能与α-蒎烯和类黄酮等植物化学物质有关,它们被认为可以调节氧化应激、炎症和细胞凋亡途径。值得注意的是,PAG可能更安全,因为它没有肾毒性作用,并具有肝肾保护特性。结论:PAG作为阿司匹林引起的溃疡的有效天然疗法,结合了粘膜保护和全身安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current molecular medicine
Current molecular medicine 医学-医学:研究与实验
CiteScore
5.00
自引率
4.00%
发文量
141
审稿时长
4-8 weeks
期刊介绍: Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews/ mini-reviews, original research articles, short communications/letters and drug clinical trial studies on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. The reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine. Periodically the journal invites guest editors to devote an issue on a basic research area that shows promise to advance our understanding of the molecular mechanism(s) of a disease or has potential for clinical applications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书